The novel nuclear factor-kappaB inhibitor LC-1 is equipotent in poor prognostic subsets of chronic lymphocytic leukemia and shows strong synergy with fludarabine (Q46195227)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The novel nuclear factor-kappaB inhibitor LC-1 is equipotent in poor prognostic subsets of chronic lymphocytic leukemia and shows strong synergy with fludarabine |
scientific article |
Statements
1 reference
The novel nuclear factor-kappaB inhibitor LC-1 is equipotent in poor prognostic subsets of chronic lymphocytic leukemia and shows strong synergy with fludarabine (English)
1 reference
Paul Brennan
1 reference
Saman Hewamana
1 reference
Thet Thet Lin
1 reference
Chris Jenkins
1 reference
Alan K Burnett
1 reference
Craig T Jordan
1 reference
Chris Fegan
1 reference
Clare Rowntree
1 reference
Chris Pepper
1 reference
1 December 2008
1 reference
14
1 reference
24
1 reference
8102-8111
1 reference
Identifiers
1 reference